TEE
PAHC icon

Tibra Equities Europe’s Phibro Animal Health PAHC Stock Holding History

Tibra Equities Europe’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,500
Closed -$644K – 390
2019
Q1 		$644K Buy
+19,500
New +$607K 0.06% 236

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Tibra Equities Europe's PAHC Position: Q2 2019 in Review

Tibra Equities Europe sold out of Phibro Animal Health (PAHC) in Q2 2019, closing a stake of 19,500 shares — an estimated $644K sold.

Tibra Equities Europe first reported a position in PAHC in Q1 2019 and held it in 1 quarter. The position peaked at $644K in Q1 2019. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2019.

  • Tibra Equities Europe reported no remaining Phibro Animal Health position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 19,500 Phibro Animal Health shares in Q2 2019, an estimated $644K.
  • Tibra Equities Europe first reported a position in Phibro Animal Health in Q1 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Phibro Animal Health position peaked at $644K in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.